Moderate and severe postendoscopic retrograde cholangiopancreatography pancreatitis despite prophylactic pancreatic stent placement: The effect of early prophylactic pancreatic stent dislodgement

Canadian Journal of Gastroenterology

Volumn 25, Issue 4, 2011, Pages 215-219

  Moffatt, Dana C ^a,b   Kongkam, Pradermchai ^a   Avula, Haritha ^a   Sherman, Stuart ^a   Fogel, Evan L ^a   Lehman, Glen A ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Complications; ERCP; Pancreatic stent; Post ERCP pancreatitis

Indexed keywords

ARTICLE; BALLOON DILATATION; CHOLANGIOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDOPROSTHESIS LOOSENING; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MANOMETRY; ODDI SPHINCTER; PANCREATITIS; POSTENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; PRIORITY JOURNAL; PROPHYLACTIC PANCREATIC STENT; PROPHYLAXIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPHINCTEROTOMY; STENT;

EID: 79960362596     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/678540     Document Type: Article

References (20)

1. Sofuni A, Maguchi H, Itoi T, et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol 2007;5:1339-46. (Pubitemid 350019054)
2. Singh P, Das A, Isenberg G, et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 2004;60:544-50. (Pubitemid 39311536)
3. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc 1991;37:383-93.
4. Smithline A, Silverman W, Rogers D, et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993;39:652-7. (Pubitemid 23282518)
5. Tarnasky PR, Palesch YY, Cunningham JT, et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998;115:1518-24. (Pubitemid 28546003)
6. Aizawa T, Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 2001;54:209-13.
7. Fogel EL, Eversman D, Jamidar P, et al. Sphincter of Oddi dysfunction: Pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002;34:280-5. (Pubitemid 34279515)
8. Norton ID, Gostout CJ, Baron TH, et al. Safety and outcome of endoscopic snare excision of the major duodenal papilla. Gastrointest Endosc 2002;56:239-43.
9. Harewood GC, Pochron NL, Gostout CJ. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 2005;62:367-70. (Pubitemid 41187937)
10. Fazel A, Quadri A, Catalano MF, et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003;57:291-4. (Pubitemid 36350781)
11. Freeman ML, Overby C, Qi D. Pancreatic stent insertion: Consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004;59:8-14. (Pubitemid 38095500)
12. Lehman GA. Endoscopic sphincter of Oddi manometry: A clinical practice and research tool. Gastrointest Endosc 1991;37:490-2.
13. Chahal P, Tarnasky PR, Petersen BT, et al. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2009;7:834-9.
14. Sherman S, Earle D, Bucksot L, et al. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? A final analysis of a randomized prospective study. Gastrointestinal Endosc 1996;43:A413.
15. Testoni PA, Bagnolo F, Caporuscio S, et al. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis. Am J Gastroenterol 1999;94:1235-41. (Pubitemid 29214635)
16. Gottlieb K, Sherman S, Pezzi J, et al. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. Am J Gastroenterol 1996;91:1553-7. (Pubitemid 26269169)
17. Thomas PR, Sengupta S. Prediction of pancreatitis following endoscopic retrograde cholangiopancreatography by the 4-h post procedure amylase level. J Gastroenterol Hepatol 2001;16:923-6. (Pubitemid 32868639)
18. Rashdan A, Fogel EL, McHenry L Jr, et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004;2:322-9. (Pubitemid 38447197)
19. Lawrence C, Cotton PB, Romagnuolo J, et al. Small prophylactic pancreatic duct stents: An assessment of spontaneous passage and stent-induced ductal abnormalities. Endoscopy 2007;39:1082-5.
20. Sherman S, Lehman GA. ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas 1991;6:350-67.